GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (LTS:0EAP) » Definitions » EV-to-EBIT

Euroapi (LTS:0EAP) EV-to-EBIT : -2.44 (As of May. 29, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Euroapi's Enterprise Value is €290.9 Mil. Euroapi's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €-119.3 Mil. Therefore, Euroapi's EV-to-EBIT for today is -2.44.

The historical rank and industry rank for Euroapi's EV-to-EBIT or its related term are showing as below:

LTS:0EAP' s EV-to-EBIT Range Over the Past 10 Years
Min: -140.9   Med: -2.11   Max: 214.23
Current: -2.44

During the past 6 years, the highest EV-to-EBIT of Euroapi was 214.23. The lowest was -140.90. And the median was -2.11.

LTS:0EAP's EV-to-EBIT is ranked worse than
100% of 691 companies
in the Drug Manufacturers industry
Industry Median: 16.75 vs LTS:0EAP: -2.44

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Euroapi's Enterprise Value for the quarter that ended in Dec. 2024 was €263.6 Mil. Euroapi's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €-119.3 Mil. Euroapi's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -45.26%.


Euroapi EV-to-EBIT Historical Data

The historical data trend for Euroapi's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi EV-to-EBIT Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial - - 184.08 -3.13 -2.22

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 184.08 - -3.13 - -2.22

Competitive Comparison of Euroapi's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Euroapi's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euroapi's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Euroapi's EV-to-EBIT falls into.


;
;

Euroapi EV-to-EBIT Calculation

Euroapi's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=290.921/-119.3
=-2.44

Euroapi's current Enterprise Value is €290.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Euroapi's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €-119.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euroapi  (LTS:0EAP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Euroapi's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=-119.3/263.590044
=-45.26 %

Euroapi's Enterprise Value for the quarter that ended in Dec. 2024 was €263.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Euroapi's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €-119.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euroapi EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Euroapi's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroapi Business Description

Traded in Other Exchanges
Address
15 rue Traversiere, Paris, FRA, 75012
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.

Euroapi Headlines

No Headlines